Literature DB >> 2857071

Alprazolam-induced dyscontrol in borderline personality disorder.

D L Gardner, R W Cowdry.   

Abstract

The authors report a significant increase in dyscontrol in patients with borderline personality disorder who were taking alprazolam during a double-blind, placebo-controlled crossover study. They suggest that caution be used in prescribing alprazolam to patients with similar histories.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2857071     DOI： 10.1176/ajp.142.1.98

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  12 in total

1.  [Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].

Authors:  T H C Krüger; M A Wollmer; P Negt; H Frieling; S Jung; K G Kahl
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

Review 2.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

Review 3.  Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs.

Authors:  M V Rudorfer; W Z Potter
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

4.  Benzodiazepines in psychotic States.

Authors:  J Ananth; O Solano
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

5.  The effects of diazepam on human self-aggressive behavior.

Authors:  Mitchell E Berman; Gabriele D Jones; Michael S McCloskey
Journal:  Psychopharmacology (Berl)       Date:  2004-08-17       Impact factor: 4.530

Review 6.  Antidepressant drugs and the emergence of suicidal tendencies.

Authors:  M H Teicher; C A Glod; J O Cole
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

7.  Pro re nata (as needed) psychotropic medication use in patients with borderline personality disorder and subjects with other personality disorders over 14 years of prospective follow-up.

Authors:  Eduardo Martinho; Garrett M Fitzmaurice; Frances R Frankenburg; Mary C Zanarini
Journal:  J Clin Psychopharmacol       Date:  2014-08       Impact factor: 3.153

8.  Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Ruth A Engelberg; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-01

9.  The injection rate of intravenous midazolam significantly influences the occurrence of paradoxical reaction in pediatric patients.

Authors:  Abbas Moallemy; Saeed Hoseini Teshnizi; Masood Mohseni
Journal:  J Res Med Sci       Date:  2014-10       Impact factor: 1.852

10.  Heightened aggression after chronic flunitrazepam in male rats: potential links to cortical and caudate-putamen-binding sites.

Authors:  Rosa Maria M de Almeida; Quelin Benini; Juliana S Betat; Débora C Hipólide; Klaus A Miczek; Anders I Svensson
Journal:  Psychopharmacology (Berl)       Date:  2007-12-14       Impact factor: 4.415
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.